T1	Intervention 38 49	lumiracoxib
T2	Intervention 91 100	celecoxib
T3	Intervention 236 247	lumiracoxib
T4	Intervention 267 301	cyclooxygenase-2 (COX-2) inhibitor
T5	Intervention 515 693	compared the effects of lumiracoxib at doses of 100 mg once daily (o.d.) and 100 mg twice daily (b.i.d.) with those of celecoxib 200 mg o.d. on retention on treatment over 1 year
T6	Intervention 918 929	lumiracoxib
T7	Intervention 953 964	lumiracoxib
T8	Intervention 994 1003	celecoxib
T9	Intervention 1100 1111	lumiracoxib
T10	Intervention 1141 1150	celecoxib
T11	Intervention 1351 1453	Short Arthritis assessment Scale (SAS) total score, rescue medication use, and safety and tolerability
T12	Intervention 1510 1521	lumiracoxib
T13	Intervention 1535 1546	lumiracoxib
T14	Intervention 1565 1574	celecoxib
T15	Intervention 1688 1699	lumiracoxib
T16	Intervention 1735 1744	celecoxib
T17	Intervention 2080 2091	lumiracoxib
T18	Intervention 2173 2182	celecoxib
